Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 27

Results For "April"

432 News Found

Godrej reveals how to win the war against Malaria through strategic collaboration
Public Health | August 20, 2022

Godrej reveals how to win the war against Malaria through strategic collaboration

~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership


Philips CEO Frans van Houten to step down; Roy Jakobs named successor
People | August 18, 2022

Philips CEO Frans van Houten to step down; Roy Jakobs named successor

The Supervisory Board has unanimously decided to propose Roy Jakobs as the next President and CEO of Royal Philips to its General Meeting of Shareholders.


Ube to buy API Corp. from Mitsubishi Chemical
News | August 09, 2022

Ube to buy API Corp. from Mitsubishi Chemical

APIC is a contract development and manufacturing organization (CDMO) that offers a wide range of services such as synthetic route design, pilot manufacturing, investigational medical manufacturing, and commercial production, by making full use of integrated processes that combine organic synthesis technologies and biotechnologies it has cultivated over many years


Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
News | July 16, 2022

Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA

ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.


Wacker to expand mRNA-based actives capacity at Halle, Germany
News | July 06, 2022

Wacker to expand mRNA-based actives capacity at Halle, Germany

Company is investing more than €100 million in the expansion of the Halle site


Biocon Biologics receives EU GMP Certification for its in Bengaluru
News | July 06, 2022

Biocon Biologics receives EU GMP Certification for its in Bengaluru

This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.


Dr. Reddy's Laboratories acquires injectable product portfolio from Eton Pharma
News | June 27, 2022

Dr. Reddy's Laboratories acquires injectable product portfolio from Eton Pharma

Dr. Reddy's acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.


Novartis receives EC approval for Tabrecta for the treatment of non-small cell lung cancer
Drug Approval | June 24, 2022

Novartis receives EC approval for Tabrecta for the treatment of non-small cell lung cancer

Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally


Alembic Pharmaceuticals shows growth in May 2022
News | June 23, 2022

Alembic Pharmaceuticals shows growth in May 2022

Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively


MedC Biopharma partners with A2W Pharma to develop cannabinoid therapeutics
News | June 22, 2022

MedC Biopharma partners with A2W Pharma to develop cannabinoid therapeutics

Bringing next-gen cannabinoid therapeutics to cancer patients